Xbrane–SEVERAL: investment, 2016 IPO SEK100m at Nasdaq First North

	Period	2016-01-01
	Region	Sweden
	Money taker	Xbrane Biopharma AB (Nasdaq Stockholm: XBRANE)
	Group	Xbrane (Group)
	Money source	SEVERAL
	Product	biopharmaceutical
	Product 2	investment banking

Record changed: 2021-12-06

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)